Hassard James
- SEC CIK
- 0001799357
No open-market purchases or sales filed in the past year.
Current role at each company
- CRNX Crinetics Pharmaceuticals, Inc.Chief Commercial Officeras of Jul 9, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Hassard James as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 9, 2024 (view filing) | Jul 5 | 4 days | Hassard JamesChief Commercial Officer | SSale | −15.0K | $44.08 | −$661.2K | −33.9%29.3K after | 10b5-1 |
| Jun 24, 2024 (view filing) | Jun 21 | 3 days | Hassard JamesChief Commercial Officer | SSale | −15.0K | $44.66 | −$669.9K | −33.9%29.3K after | 10b5-1 |